Added to YB: 2026-06-18
Pitch date: 2026-06-16
VIRP.PA [neutral]
Virbac SA
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.
Market Cap
EUR 2.8B
Pitch Price
N/A
Price Target
N/A
Dividend
0.43%
EV/EBITDA
10.29
P/E
18.72
EV/Sales
2.04
Sector
Pharmaceuticals
Category
growth
Virbac (VIRP France): Merger speculation
VIRP.PA (update): Céva chairman floated merger to build French animal-health champion (Céva €1.9bn rev vs Virbac €1.5bn), but Virbac flatly denied talks. Dick family prioritizes independence. Standalone case: ~60 launches by 2030, op margin 17%→20%, secular pet/livestock tailwinds. Merger seen unlikely.
Read full article (2 min)